Low Concordance with the DASH Plan Is Associated with Higher Cardiovascular Risk in Treated Hypertensive Patients
Table 2
Clinical and laboratory data of study population.
Variables
LC group (n = 33)
HC group (n = 47)
P value
Age (years)
54 ± 7
54 ± 8
0.934
Female (n (%))
22 (66.7)
39 (83.0)
0.091
Sedentary lifestyle (n (%))
28 (84.8)
32 (68.1)
0.088
BMI (Kg/m²)
30.4 ± 4.9
30.2 ± 6.5
0.889
Waist (cm)
Women
98 ± 12
95 ± 15
0.433
Men
99 ± 10
94 ± 7
0.332
WHR (units)
Women
0.91 ± 0.05
0.87 ± 0.08
0.064
Men
0.97 ± 0.05
0.93 ± 0.04
0.107
SBP (mmHg)
147 ± 22
133 ± 16
0.002
DBP (mmHg)
91 ± 15
83 ± 10
0.006
Glucose (mmol/L)
5.23 ± 0.79
5.11 ± 0.78
0.514
Creatinine (μmol/L)
79.5 ± 24.7
71.6 ± 19.4
0.098
Total cholesterol (mmol/L)
5.39 ± 0.84
5.35 ± 0.95
0.859
HDL-cholesterol (mmol/L)
Women
1.27 ± 0.37
1.47 ± 0.33
0.043
Men
1.06 ± 0.23
1.09 ± 0.19
0.750
LDL-cholesterol (mmol/L)
3.46 ± 0.85
3.30 ± 0.99
0.486
Triglycerides (mmol/L)
1.75 ± 1.12
1.44 ± 0.72
0.144
Cardiovascular Risk (%)
18 ± 9
10 ± 7
0.001
Vascular age (years)
75 ± 11
66 ± 13
0.003
Use of cardiovascular drugs (%)
Thiazide diuretics
26 (78.8)
34 (72.3)
0.512
Betablockers
16 (48.5)
24 (51.1)
0.820
Calcium channel blockers
5 (15.2)
13 (27.7)
0.187
ACE inhibitors
19 (57.6)
23 (48.9)
0.446
Angiotensin II receptor blockers
2 (6.1)
6 (12.8)
0.325
All values are mean ± SD or proportions when indicated. LC: lower concordance; HC: higher concordance; BMI: body mass index; WHR: waist-to-hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL: high density lipoprotein; LDL: low density lipoprotein; ACE: angiotensin-converting enzyme.
